Outlook Therapeutics Inc (OTLK)

Finanzdaten der Outlook Therapeutics Inc-Aktie (OTLK)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1,735% -3.084	0.1887	0.3058	0.3952	0.1878
Operating Expenses	80.18% 18.94	10.51	12.76	18.54	7.0257
Benefits Costs and Expenses	111.20	-	13.30	21.07	6.8393
Costs And Expenses	957.88% 111.20	10.51	13.30	21.07	6.8393
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	0.00% 0.0282	0.0282	0.0112	0.0112	0.011
Operating Income/Loss	83.47% -18.94	-10.32	-12.46	-18.14	-6.8379
Net Interest Income/Expense	1,735% -3.084	0.1887	0.3058	0.3952	0.1878
Interest Income/Expense After Provision For Losses	1,735% -3.084	0.1887	0.3058	0.3952	0.1878
Income/Loss Before Equity Method Investments	61,485% -114.26	0.1861	-12.98	-20.67	-6.6345
Income/Loss From Equity Method Investments	1,301% -0.0306	0.00255	-0.00835	-0.00719	-0.017
Income/Loss From Continuing Operations Before Tax	922.40% -114.29	-11.18	-12.99	-20.68	-6.6515
Income Tax Expense/Benefit	0.0028	-	-	-	0.0028
Income/Loss From Continuing Operations After Tax	922.42% -114.29	-11.18	-12.99	-20.68	-6.6543
Net Income/Loss	922.42% -114.29	-11.18	-12.99	-20.68	-6.6543
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.52% 14.27	260.26	3.2974	256.88	256.67
Diluted Average Shares	94.52% 14.27	260.26	3.2974	256.88	256.67
Basic Earnings Per Share	19,925% -8.01	-0.04	-0.05	-0.08	-0.03
Diluted Earnings Per Share	19,925% -8.01	-0.04	-0.05	-0.08	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-